Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
SLNO
#1667
Soleno Therapeutics, Inc. Common Stock
39.0
7
+5.51%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+5.51%
Aylık değişim
-9.20%
6 aylık değişim
-42.34%
Yıllık değişim
-13.27%
Önceki kapanış
37.0
3
Open
39.0
7
Bid
Ask
Low
39.0
7
High
39.0
7
Hacim
143
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
SLNO
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
5.31 M
5.34 M
8.17 M
32.46 M
45.86 M
51.62 M
—
Valuation ratios
Enterprise value
—
—
3.29 M
1.06 B
1.97 B
2.32 B
13.6 B
Price to earnings ratio
—
—
-0.76
-16.08
-10.26
118.72
49.49
Price to sales ratio
—
—
—
—
—
12.74
—
Price to cash flow ratio
—
—
-0.88
-25.1
-26.14
51.83
-120.95
Price to book ratio
—
—
1.78
3.97
7.37
5.39
14.46
Enterprise value to EBITDA ratio
—
—
—
—
—
267.08
—
Profitability ratios
Return on assets %
0.38
0.87
0.91
0.22
0.53
0.04
0.1
Return on equity %
0.54
1.74
2.33
0.25
0.72
0.05
0.14
Return on invested capital %
275.44
1 091.59
904.19
1 615.72
3 509.39
26.23
—
Gross margin %
—
—
—
—
—
98.58
—
Operating margin %
—
—
—
—
—
4.94
—
EBITDA margin %
—
—
—
—
—
4.56
—
Net margin %
—
—
—
—
—
10.97
—
Liquidity ratios
Quick ratio
—
—
—
—
—
5.55
—
Current ratio
5.83
2.8
2.14
14.89
15.68
5.8
56.65
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
0.43
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
0.15
0.09
—
Long term debt to total equity ratio
—
—
—
—
0.2
0.11
—
Per share metrics
Operating cash flow per share
—
—
2.48
1.51
1.72
0.89
1.02
EBIT per share
—
—
—
—
—
0.13
—
EBITDA per share
—
—
—
—
—
0.17
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
1.74
10.29
7.25
5.83
26.88
Net current asset value per share
—
—
1.86
10.39
7.32
6.79
29.5
Tangible book value per share
—
—
-0.04
9.02
5.93
8.5
26.95
Working capital per share
—
—
0.99
9.69
6.85
5.62
26.96
Book value per share
—
—
1.23
9.55
6.1
8.59
27.39
Haberler
Soleno Therapeutics stock hits 52-week low at 36.01 USD
Soleno Therapeutics names Jennifer Fulk as CFO
Soleno Therapeutics earnings beat by $0.19, revenue topped estimates
Soleno Therapeutics lansman verileri incelenirken kazanç testiyle karşı karşıya
Soleno Therapeutics faces earnings test as launch metrics scrutinized
Soleno Therapeutics stock hits 52-week low at 37.95 USD
Ultragenyx Pharmaceutical Resubmits UX111 BLA for Sanfilippo Syndrome
Down 18.3% in 4 Weeks, Here's Why Soleno Therapeutics (SLNO) Looks Ripe for a Turnaround
FDA Accepts SMMT's Application Seeking Approval for NSCLC Drug
Soleno Therapeutics hissesi 39,42 dolar ile 52 haftalık dibe geriledi
Soleno Therapeutics stock hits 52-week low at 39.42 USD
HCA Healthcare Q4 Earnings Beat Estimates on Strong Patient Volumes